FDA Inspection 1210971 - Boehringer Ingelheim RCV GmbH & Co KG - March 02, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Boehringer Ingelheim RCV GmbH & Co KG, with an inspection on March 2, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Boehringer Ingelheim RCV GmbH & Co KG
Inspection Date: March 2, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 3cfa7c2f-3876-4a03-8a8f-2b34332d7f2c